|

GST-HG131 Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Fujian Akeylink Biotechnology Co., Ltd.2

Indications

Other2 trials

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Phase 2
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.